Mice were anesthetized with a mixture of ketamine (Fort Dodge Animal Health, Fort Dodge, IA, USA), xylazine (VedCo, Inc., Saint Joseph, MO, USA), and acepromazine (Phoenix Pharmaceuticals, Burlingame, CA, USA; 50, 10, and 2 mg/kg, respectively). One anterior chamber was injected with Polybead Microspheres (Polysciences, Inc., Warrington, PA, USA), consisting of 2 μL of 6-μm diameter beads and then 2 μL of 1-μm diameter beads followed by 1 μL of viscoelastic compound (10 mg/mL sodium hyaluronate, Healon; Advanced Medical Optics, Inc., Santa Ana, CA, USA). The injections were made through a 50-μm diameter tip glass cannula connected to a Hamilton syringe (Hamilton, Inc., Reno, NV, USA). We measured IOP with the Tonolab tonometer (TioLat, Inc., Helsinki, Finland) under anesthesia by inhalation of isoflurane using the RC2-Rodent Circuit Controller (VetEquip, Inc., Pleasanton, CA, USA).